Your browser doesn't support javascript.
loading
The Tubulin Inhibitor VERU-111 in Combination With Vemurafenib Provides an Effective Treatment of Vemurafenib-Resistant A375 Melanoma.
Cui, Hongmei; Wang, Qinghui; Miller, Duane D; Li, Wei.
Affiliation
  • Cui H; Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States.
  • Wang Q; Institute of Toxicology, School of Public Health, Lanzhou University, Lanzhou, China.
  • Miller DD; Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States.
  • Li W; Department of Pharmaceutical Sciences, University of Tennessee Health Science Center, Memphis, TN, United States.
Front Pharmacol ; 12: 637098, 2021.
Article in En | MEDLINE | ID: mdl-33841154
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2021 Document type: Article Affiliation country: Country of publication: